(Q52083297)

English

A pharmacoeconomic model for the treatment of influenza.

scientific article published in January 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/10623380

A pharmacoeconomic model for the treatment of influenza. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/10623380

author name string

J A Mauskopf

1

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/10623380

S C Cates

2

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/10623380

A D Griffin

3

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/10623380

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/10623380

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/10623380

16 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/10623380

73-84

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/10623380

https://scigraph.springernature.com/pub.10.2165/00019053-199916001-00010

0 references

The swine-influenza decision

1 reference

https://pubmed.ncbi.nlm.nih.gov/10623380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10623380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10623380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical features of influenza.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10623380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of three influenza epidemics on primary care in England and Wales

1 reference

https://pubmed.ncbi.nlm.nih.gov/10623380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic effects of aerosolized amantadine in naturally acquired infection due to influenza A virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/10623380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/10623380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of influenza vaccination and economic modelling. Can results be pooled?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10623380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78

1 reference

https://pubmed.ncbi.nlm.nih.gov/10623380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Influenza: incidence and costs of inpatient treatment]

1 reference

https://pubmed.ncbi.nlm.nih.gov/10623380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-influenza vaccination for active persons (25-64 years): a cost-benefit study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10623380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10623380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact and cost of influenza in the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/10623380

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-199916001-00010

0 references

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 April 2018

http://europepmc.org/abstract/MED/10623380

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52083297&oldid=1698379242"